See every side of every news story
Published loading...Updated

#Legal Repercussions for Actinium Pharmaceuticals An Analysis of Recent Developments and Market Performance

Summary by csimarket.com
In a significant development within the pharmaceutical sector, Gainey McKenna & Egleston has announced the initiation of a class-action lawsuit against Actinium Pharmaceuticals, Inc. (NYSE: ATNM). The case, formally filed in the United States District Court for the Southern District of New York, aims to represent individuals and entities who acquired or purchased securities of Actinium between October 31, 2022, and August 2, 2024 (the Class Peri…

2 Articles

All
Left
Center
1
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Friday, March 28, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.